Illustrative indicators from the SRH Self-Care Measurement Tool, by intervention and measurement domain
| Domain | No. | Indicator name | Purpose | Where it’s being used |
| DMPA-SC SI | ||||
| Enabling environment | 4 | Status of policy that authorises private sector staff to initiate SI | Expanding access by reaching women who tend to rely on the private sector for their contraceptive methods | Routine reporting for the DMPA-SC Donor Consortium: Access Collaborative dashboard (https://dashboard.access-collaborative.com); AC country briefs (https://fpoptions.org/resource/ac-country-briefs/) |
| KAP (knowledge) | 12 | Percentage of women aged 15–49 who have heard of a self-injectable contraceptive | Gauging knowledge as a precursor for informed decision-making | The Performance Monitoring for Action (PMA) surveys (https://www.pmadata.org/data/survey-methodology) |
| KAP (practices) | 18 | Among current DMPA-SC users, percentage of women aged 15–49 who self-injected their current method | Understanding prevalence of SI | The Performance Monitoring for Action (PMA) surveys (https://www.pmadata.org/data/survey-methodology) |
| Service delivery and health outcomes | 20 | Number and percentage of service delivery points (SDPs) actively offering SI services | Measuring availability and access, including geographic scope of availability of SI services | Routine reporting for the DMPA-SC Donor Consortium Access Collaborative dashboard & SI quarterly report (https://dashboard.access-collaborative.com) |
| HIV self-testing indicators | ||||
| Enabling environment | 33 | Number of HIVST products approved annually, among those with WHO prequalification | Understanding number of HIVST kits pre-qualified (PQed) or listed by Stringent Regulatory Authority (SRA)/Expert Review Panel for Diagnostics (ERPD). | Collected biannually by WHO |
| KAP (knowledge) | 38 | Percentage of HIVST users who would recommend HIVST to a friend | Measuring client satisfaction which covers both their satisfaction with the actual product (ease of use) as well as their satisfaction with the information they received to prepare them to use the product | PSI’s Strengthening HIVST in the Private Sector (SHIPS) project. Data are collected through opt-in chatbot surveys but could also be collected through a more widespread consumer survey |
| Service delivery and health outcomes | 49 | Number of people newly enrolled on antiretroviral therapy who report self-test use | Estimating impact of HIVST through use in data triangulation | Usually collected in national DHIS2 |
| Self-managed abortion | ||||
| Enabling environment | 53 | National essential medicines list includes combination mifepristone and misoprostol, or misoprostol and mifepristone as separate presentations | Identifying targets to strive for or maintain in area of medicines and other health products | GAPD; IPPF Medical Abortion Commodities Database WHO/HRP multi-country initiative health system monitoring |
| KAP (knowledge) | 56 | Percentage of individuals who understand what to expect at each step of the self-managed abortion process | Ensuring quality of abortion care, specifically provision of information to prepare clients | ACQTool, indicator #21 (https://www.acqtool.org/metric/indicators/) |
| Service delivery and health outcomes | 61 | Percentage of respondents who reported feeling prepared to determine if their abortion was complete | Facilitating quality SMA requires information and support about abortion completeness. This includes effective communication and preparedness | Field-tested and validated as part of ACQ project ACQTool, indicator #24 (https://www.acqtool.org/metric/indicators/) |
AC, Access Collaborative; ACQ, Abortion Care Quality; DHIS2, District Health Information Software; DMPA, subcutaneous depot medroxyprogesterone acetate; GAPD, Global Abortion Policies Database; HIVST, HIV self-testing; HRP, Human Reproduction Programme; IPPF, International Planned Parenthood Federation; KAP, knowledge, attitude, practices; PSI, Population Services International; SI, self-injection; SMA, self-managed abortion; SRH, sexual and reproductive health.